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Summary
 
Natural killer (NK) cells are named based on their natural cytotoxic activity against a variety of
target cells. However, the mechanisms by which sensitive targets activate killing have been dif-
ficult to study due to the lack of a prototypic NK cell triggering receptor. Pharmacologic evi-
dence has implicated protein tyrosine kinases (PTKs) in natural killing; however, Lck-deficient,
Fyn-deficient, and ZAP-70–deficient mice do not exhibit defects in natural killing despite de-
monstrable defects in T cell function. This discrepancy implies the involvement of other ty-
rosine kinases. Here, using combined biochemical, pharmacologic, and genetic approaches, we
demonstrate a central role for the PTK Syk in natural cytotoxicity. Biochemical analyses indi-
cate that Syk is tyrosine phosphorylated after stimulation with a panel of NK-sensitive target
cells. Pharmacologic exposure to piceatannol, a known Syk family kinase inhibitor, inhibits
natural cytotoxicity. In addition, gene transfer of dominant-negative forms of Syk to NK cells
inhibits natural cytotoxicity. Furthermore, sensitive targets that are rendered NK-resistant by
major histocompatibility complex (MHC) class I transfection no longer activate Syk. These
data suggest that Syk activation is an early and requisite signaling event in the development of
natural cytotoxicity directed against a variety of cellular targets.
 
T
 
he NK cell is a type of lymphocyte that is able to me-
diate natural cytotoxicity against a variety of tumor
cells, virus-infected cells, and hematopoietic targets (1).
However, little is known regarding the mechanisms by
which these targets trigger natural cytotoxicity. In addition
to natural cytotoxicity, the NK cell can mediate antibody-
dependent cell-mediated cytotoxicity (ADCC)
 
1
 
 through its
FcR for IgG, Fc
 
g
 
RIII. In contrast to natural cytotoxicity,
ADCC is well defined with respect to the receptor–ligand
interaction as well as intracellular second messenger in-
volvement (for review see reference 2). In spite of this con-
trast between the well-defined FcR-dependent and the
poorly defined natural cytotoxic mechanisms, both killing
mechanisms can be inhibited by MHC-recognizing killer
cell inhibitory receptors (KIR). Since KIR inhibition
seems to target signaling pathways initiated by immunore-
ceptor tyrosine-based activation motif (ITAM)–containing
receptor complexes (e.g., Fc
 
g
 
RIII, TCR, and Fc
 
e
 
RI; ref-
erences 3–9), the ability of both FcR-dependent and natu-
ral cytotoxicity to be inhibited by KIR suggests that there
may be shared signaling elements in the pathways used dur-
ing the two alternative routes of initiating NK cell–medi-
ated cytotoxicity.
Evidence using the PTK inhibitors herbimycin A and
genistein demonstrates that PTK activation is necessary for
both FcR-mediated and natural cytotoxicity (10–14). How-
ever, the available genetic evidence from Lck- and Fyn-defi-
cient mice suggests that neither of these specific Src family
tyrosine kinases is necessary for NK cell–mediated cytotox-
icity (15, 16). This raises the possibility that another Src
family PTK (e.g., Lyn) could subserve this role. Alterna-
tively, the receptors initiating NK cell–mediated killing
could use a different kind of PTK that might function in a
Src family kinase-independent manner. The Syk family
member ZAP-70, which is expressed in NK cells, is un-
likely to be this PTK because ZAP-70 appears to require
activation by a Src family PTK (17–20); and because NK
cells from humans and mice lacking ZAP-70 can mediate
normal natural cytotoxicity and ADCC (21–23). In con-
trast, Syk itself could perform this role. Syk is expressed in
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NK cells (24) and evidence suggests that Syk is able to
function in the absence of Src family kinases (18–20, 25).
Although chimeric receptors containing the intracellular
portion of ZAP-70 require cross-linking with Src family
kinases such as Lck or Fyn to mediate cytotoxicity, chi-
meric receptors containing Syk can initiate killing in the
absence of Src family PTK costimulation (18). In addition,
Syk, but not ZAP-70, can induce the tyrosine phosphory-
lation of ITAM-containing receptor subunits in an Src
family PTK-independent manner (19, 20, 25).
To test the hypothesis that the Syk tyrosine kinase is
functionally involved in natural cytotoxicity, we first stim-
ulated NK cells with a panel of sensitive targets and then
characterized their intracellular signaling events. Although
stimulation of NK cells with sensitive targets is known to
induce increases in intracellular free Ca
 
2
 
1
 
 and inositol phos-
phate release (26–30), more proximal specific signaling events
have not been elucidated. In this study, we describe a rapid
and reversible increase in the tyrosine phosphorylation of
NK cell–derived Syk after target cell stimulation. In addi-
tion, either pharmacologic inhibition of Syk kinase activity
or expression of dominant-negative, kinase-inactive Syk in
NK cells inhibits natural killing. Finally, tumor cells that
are made resistant to NK cell–mediated cytotoxicity by
MHC class I transfection no longer activate Syk. Together
these data emphasize the central contribution of the Syk ty-
rosine kinase to generation of natural cytotoxicity.
 
Materials and Methods
 
Cells, Chemicals, and Abs.
 
The P815 cell line (murine masto-
cytoma) was obtained from American Type Culture Collection
(Rockville, MD). The HLA class I–deficient C1R cell line
(B-LCL) and its HLA-transfected derivatives were supplied by
Peter Cresswell (Yale University, New Haven, CT). The HLA
class I–deficient cell line 721.221 (B-LCL) was provided by Peter
Parham (Stanford University, Palo Alto, CA). Human PBL were
isolated from defibrinated blood by Ficoll-Hypaque density cen-
trifugation. Human CD16
 
1
 
 NK cell lines were isolated and char-
acterized as previously described (29). All chemicals, unless other-
wise noted, were obtained from Sigma Chemical Co. (St. Louis,
MO). The 3G8 hybridoma (anti-Fc
 
g
 
RIII) was provided by Bice
Perussia (Thomas Jefferson University, Philadelphia, PA; refer-
ence 31) and 3G8 mAb was purified by affinity chromatography
over protein A agarose. The generation and characterization of
rabbit antisera specific for ZAP-70 have been previously de-
scribed (32). The 4D10 mAb specific for Syk was purchased from
Santa Cruz Biotechnology (Santa Cruz, CA). The antiphospho-
tyrosine mAb 4G10 was purchased from Upstate Biotechnology
Inc. (Lake Placid, NY).
 
Cytotoxicity Assays.
 
The 
 
51
 
Cr-release assays measuring direct
NK cell–mediated cytotoxicity were performed as previously de-
scribed (29). For experiments evaluating the effects of piceatannol
(Boehringer Mannheim, Indianapolis, IN), cloned human NK
cells were pretreated with the indicated concentration of the drug
for 15 min at 37
 
8
 
C. Lytic units were calculated based on 20% cy-
totoxicity (33).
 
Vaccinia Viruses.
 
ZAP-70K cDNA was excised from pcDNA3.
KD.myc.Zap70 (provided by Lawrence E. Samelson, National
Institutes of Health, Bethesda, MD; reference 34) with BamHI/
 
NotI, and blunt-ended with Klenow. The blunt-ended ZAP-70K
fragment was inserted into the SmaI cloning site of the vector
pSC11 and introduced into WR strain vaccina virus via homolo-
gous recombination. Recombinant vaccinia viruses encoding
wild-type Syk, wild-type ZAP-70, SykT, and SykK as well as the
pSC-65 vector were provided by Jean-Pierre Kinet and Andrew
M. Scharenberg (Harvard Medical School, Boston, MA; refer-
ences 35, 36). For infections, NK cells (2 
 
3
 
 10
 
6
 
 cells/ml) were
incubated in serum-free RPMI 1640 for 1 h at 37
 
8
 
C at a multi-
plicity of infection of 20. Cells were then incubated for the re-
mainder of the indicated infection time at 10
 
6
 
 cells/ml in RPMI
1640 supplemented with 10% bovine calf serum.
 
Whole Cell Lysates, Cell Stimulation, Immunoprecipitation, and Im-
munoblot Analysis.
 
For whole cell lysates, 1.5 
 
3
 
 10
 
6
 
 NK cells
were lysed in buffer containing 10 mM Tris (pH 7.4), 50 mM
NaCl, 5 mM EDTA, 50 mM NaF, 30 mM Na
 
4
 
P
 
2
 
O
 
7
 
, and 1%
Triton X-100 (pH 7.4). Protein levels were determined using the
BCA Protein Assay (Pierce, Rockford, IL) and equal amounts of
protein were resolved by SDS-PAGE. For cell stimulation, NK
cells were resuspended at 10
 
8
 
/ml and target cells were resus-
pended at 5 
 
3
 
 10
 
7
 
/ml in RPMI 1640 supplemented with 0.5%
BSA. 100 
 
m
 
l of NK cells were mixed with 100 
 
m
 
l of target cells
(effector/target ratio of 2:1), pelleted at 5,000 rpm for 5 s, and
then incubated at 37
 
8
 
C for the indicated time. For anti-FcR stim-
ulation, NK cells were incubated at 4
 
8
 
C for 3 min with anti-
Fc
 
g
 
R mAb (3G8; 10 
 
m
 
g/ml). Washed cells were then mixed
with goat anti–mouse IgG F(ab
 
9
 
)
 
2
 
 fragments (Organon Teknika-
Cappel, Durham, NC), rapidly pelleted, and incubated for 1 min
at 37
 
8
 
C. After stimulation, cells were lysed in buffer containing
20 mM Tris-HCl, 40 mM NaCl, 5 mM EDTA, 50 mM NaF, 30
mM Na
 
4
 
P
 
2
 
O
 
7
 
, 0.1% BSA, 1 mM Na
 
3
 
VO
 
4
 
, 1 mM PMSF, 5 
 
m
 
g/
ml aprotinin, 10 
 
m
 
g/ml leupeptin, and 1% Triton X-100 (pH
7.4). Samples were centrifuged at 15,000 
 
g
 
 for 5 min to remove
insoluble material. Supernatants were subjected to immunopre-
cipitation with either rabbit antiserum specific for ZAP-70 bound
to protein A–Sepharose beads or with anti-Syk mAb 4D10
bound to either protein A–Sepharose or goat anti–mouse IgG
agarose beads. Immunoprecipitates were washed and bound pro-
teins were eluted with 50 
 
m
 
l of SDS-sample buffer. Proteins re-
solved by SDS-PAGE were electrophoretically transferred to Im-
mobilon-P membranes (Millipore, Bedford, MA).
Tyrosine phosphorylated proteins and Syk expression were de-
tected with the 4G10 and 4D10 mAbs, respectively, followed by
sheep anti–mouse IgG coupled to horseradish peroxidase (Amer-
sham International, Buckinghamshire, England). ZAP-70 expres-
sion was analyzed with ZAP-70–specific rabbit antisera and de-
tected with protein A–horseradish peroxidase and the ECL
detection system from Amersham.
 
32
 
P-labeling and Phosphoamino Acid Analysis.
 
NK cells were washed
with phosphate-free RPMI 1640 medium supplemented with 4%
bovine calf serum and 1% 
 
l
 
-glutamine. Cells were labeled with
0.5 mCi of [
 
32
 
P]orthophosphate/ml for 3 h at 37
 
8
 
C at 1.5 
 
3
 
 10
 
7
 
cells/ml in phosphate-free medium, washed twice, and then re-
suspended at 10
 
8
 
 cells/ml, and 100 
 
m
 
l of NK cells were used for
stimulation. Target cells were also washed with phosphate-free me-
dia (not containing [
 
32
 
P]orthophosphate) before use for cell stim-
ulation.
For phosphoamino acid analysis, portions of the membrane
corresponding to Syk on the autoradiogram were cut and boiled
in 6 N HCl for 1 h at 110
 
8
 
C to elute the protein. Membrane
fragments were rinsed twice with water and rinses were com-
bined with eluate. Eluate plus rinse was dried in a speed-vac and
resuspended in water/ethanol/methanol (10:5:1) before spotting 
1967
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on thin-layer chromatography (TLC) plates. Two cycles were
run in solvent ethanol/ammonium hydroxide/water (105:42:6)
with phosphoamino acid standards. TLC plates were sprayed with
0.2% ninhydrin in ethanol before exposure to film.
 
Results
 
NK-sensitive Targets Induce Tyrosine Phosphorylation of NK
Cell Syk.
 
Although PTK activation is an early and requi-
site event in the generation of natural cytotoxicity (10, 11),
genetic evidence suggests that the PTKs Lck, Fyn, and
ZAP-70 are not required (15, 16, 21–23). These observa-
tions prompted us to evaluate whether the tyrosine kinase
Syk is important for natural cytotoxicity. We first deter-
mined whether Syk was tyrosine phosphorylated after stim-
ulation of NK cells with sensitive targets since an increase
in Syk tyrosine phosphorylation correlates with increased
Syk activation. Human NK cell clones were incubated ei-
ther with the MHC class I–deficient B lymphoblastoid tar-
gets C1R or 721.221 or with the prototypic human NK
cell target K562. After various times of incubation, cells
were lysed and Syk was immunoprecipitated. We observed
an increase in Syk tyrosine phosphorylation after NK cells
were stimulated with each of the panel of targets (Fig. 1,
 
A–C
 
). This increase in Syk tyrosine phosphorylation was a
relatively early event, peaking at 5 min and declining to
baseline by 60 min (Fig. 2). Since both Syk family members
Syk and ZAP-70 are expressed in NK cells and activated
downstream of the FcR (24, 32, 37), we questioned
whether NK cell–derived ZAP-70 was also tyrosine phos-
phorylated after incubation with sensitive targets. ZAP-70
immunoprecipitates from target cell–stimulated lysates re-
vealed no increase in the tyrosine phosphorylation of ZAP-
70 after target cell contact (Fig. 1, 
 
A–C
 
). This was not a
defect in the ability of ZAP-70 to be phosphorylated in
these NK cells since cross-linking with FcR-specific anti-
bodies on the same cells results in an increase in ZAP-70
tyrosine phosphorylation (Fig. 1, 
 
A–C
 
). Thus, it appears
that Syk and not ZAP-70 is activated when this panel of
targets is used to stimulate NK cells. Consistent with the
observations that both Syk and ZAP-70 are tyrosine phos-
phorylated after FcR ligation (24, 32, 37), stimulation of
NK cells with the 3G8 hybridoma, which expresses mem-
brane-bound antibody to the FcR, resulted in an increase
in both Syk and ZAP-70 tyrosine phosphorylation (Fig. 3).
These data suggest that while FcR cross-linking can stimu-
late the tyrosine phosphorylation of Syk and ZAP-70, stim-
ulation of NK cells with this panel of sensitive targets re-
sults in the phosphorylation of Syk without detectable
ZAP-70 phosphorylation.
Although Syk activation has not been described in tumor
cells undergoing cell death, we could not formally exclude
the possibility that the endogenous Syk in the above panel
of targets was undergoing tyrosine phosphorylation. To en-
sure that the observed increase in tyrosine phosphorylation
was NK cell–derived Syk, NK cell clones were labeled
with [
 
32
 
P]orthophosphate before cellular target stimulation.
Indeed, Syk immunoprecipitates showed an increase in 
 
32
 
P
Figure 1. Tyrosine phosphorylation of Syk after stimulation of NK cells with targets. For each sample, 107 NK cells were mixed with 5 3 106 cells of
either (A) C1R, (B) 721.221, or (C) K562, pelleted, and incubated at 378C for the indicated times. For anti-FcR stimulation, NK cells were incubated
for 1 min with cross-linked anti-FcR mAb (3G8). Syk or ZAP-70 immunoprecipitates were resolved by SDS-PAGE, transferred to membrane, and
probed sequentially with antiphosphotyrosine mAb (P-tyr), anti-Syk mAb (Syk), and anti-ZAP-70 antiserum (ZAP-70).
Figure 2. Kinetics of Syk ty-
rosine phosphorylation after
stimulation of NK cells with tar-
gets. For each sample, 107 NK
cells were mixed with 5 3 106
C1R target cells, pelleted, and
incubated at 378C for the indi-
cated times. Syk immunoprecip-
itates were resolved by SDS-
PAGE, transferred to membrane,
and probed sequentially with an-
tiphosphotyrosine mAb (P-Tyr)
and anti-Syk mAb (Syk).
Figure 3. Anti-FcR–bearing hybridomas induce tyrosine phosphoryla-
tion of Syk and ZAP-70. NK cells were stimulated with the 3G8 hybri-
doma or cross-linked 3G8 mAb as in Fig. 2. Syk or ZAP-70 immunopre-
cipitates were resolved by SDS-PAGE, transferred to membrane, and
probed with antiphosphotyrosine mAb (P-tyr) and either anti-Syk mAb
or anti-ZAP-70 antiserum. 
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incorporation of a band at 72 kD after stimulation (Fig. 4).
A phosphotyrosine blot overlays a 72-kD radiolabeled band
on the autoradiogram. Phosphoaminoacid analysis of the
72-kD band illustrates that the increase in 
 
32
 
P incorporation
is due to an increase in phosphotyrosine and phosphoserine
(data not shown). These data support the conclusion that
NK cell–derived Syk is tyrosine phosphorylated after stim-
ulation with NK-sensitive tumor targets.
 
Piceatannol Pretreatment Inhibits Natural Cytotoxicity.
 
Al-
though the above data demonstrate biochemically that Syk
is modified in NK cells after target cell stimulation, a func-
tional requirement of Syk for cytotoxicity remained to be
demonstrated. To assess whether Syk family tyrosine kinase
activity is required for natural cytotoxicity, we used the
PTK inhibitor piceatannol (38). Syk has previously been
shown to be 10-fold more sensitive to piceatannol treat-
ment than Lyn, an Src family member, in in vitro kinase as-
says (38). Pretreatment of NK cell clones with piceatannol
inhibited natural cytotoxicity and FcR-initiated killing in a
concentration-dependent fashion with half-maximal inhi-
bition at a concentration of 
 
z
 
6 
 
m
 
g/ml (Fig. 5). This 50%
inhibitory concentration is consistent with the concentra-
tion that exhibits specific inhibition of Syk in vitro kinase
activity. These results suggest that the tyrosine kinase activ-
ity of the Syk family is functionally required for natural cy-
totoxicity.
 
Syk Overexpression Enhances Natural Cytotoxicity Whereas
Kinase-inactive Syk Expression Inhibits Killing.
 
Although the
data using piceatannol are consistent with a required role
for Syk family PTK in the development of natural cytotox-
icity, conclusions from pharmacologic approaches must be
tempered by concerns regarding potential drug effects on
other second messenger molecules. To further define a role
for Syk in natural cytotoxicity, we took a genetic approach
to express wild-type or kinase-inactive forms of Syk family
members and to evaluate the effects on natural cytotoxicity.
We used the vaccinia virus expression system to overex-
press wild-type or kinase-inactive forms of the two Syk
family members, Syk and ZAP-70, in NK cell clones. Two
different Syk mutations were used. The SykT mutant,
which has recently been shown to act as a dominant-nega-
tive in mast cells (35), is truncated at residue 395 so as to
lack the kinase domain but contain the SH2 domains. The
kinase-inactive SykK mutant has a point mutation at resi-
due 395 (K to R) that is within the ATP-binding region of
the kinase domain. Kinase inactive ZAP-70 (ZAP-70K)
also has a K to R point mutation at residue 369 within the
kinase domain. After a 4 h infection with virus containing
the coding sequences either for wild-type Syk family PTK,
mutant Syk family PTK, or the control vector, NK cell
function was assessed in a 
 
51
 
Cr-release assay. Overexpres-
sion of wild-type Syk with vaccinia enhanced natural kill-
ing whereas wild-type ZAP-70 overexpression did not
(Fig. 6). The kinase-inactive mutants of Syk (SykT, SykK)
but not ZAP-70 (ZAP-70K) acted as dominant-negatives
to inhibit natural killing (Fig. 6). Although the latter obser-
vation is consistent with the notion that ZAP-70 is not re-
quired for natural cytotoxicity, one cannot exclude the
possibility that the inability of ZAP-70K to inhibit killing is
due to insufficient expression of the transfected gene prod-
uct. Therefore, we took a genetic approach to directly ana-
lyze this issue. Specifically, we derived NK cell clones from
a patient with ZAP-70 deficiency (Fig. 7 
 
A
 
) and found that
these clones mediated wild-type levels of natural killing
(Fig. 7 
 
B
 
) as previously reported (21, 22). Taken together,
the above results suggest a required role for Syk, but not
ZAP-70, in natural killing. It should be emphasized that al-
though our data indicate that ZAP-70 activity is not neces-
Figure 4. 32P incorporation into NK cell–derived Syk. 107 32P-labeled
NK cells were mixed with 5 3 106 cells of the indicated target (K562 or
C1R), pelleted, and incubated at 378C for the indicated times. Syk im-
munoprecipitates were resolved by SDS-PAGE, transferred to mem-
brane, and exposed to x-ray film (Syk) followed by probing with an-
tiphosphotyrosine mAb (P-tyr blot). cpm from phosphoamino acid analysis
were: NK 1 K562 — 59: 2.3-fold increase in [32P]Tyr, 2-fold increase in
[32P]Ser; NK 1 K562 — 109: 1.5-fold increase in [32P]Tyr, 1.5-fold in-
crease in [32P]Ser; NK 1 C1R — 59: 2.4-fold increase in [32P]Tyr, 1.6-
fold increase in [32P]Ser; NK 1 C1R — 109: 5.4-fold increase in
[32P]Tyr, 2.5-fold increase in [32P]Ser.
Figure 5. Piceatannol pre-
treatment inhibits NK cell–
mediated cytotoxicity. NK cells
were treated for 15 min at 378C
with the indicated concentra-
tion of piceatannol, washed, and
then incubated for 4 h with ei-
ther 51Cr-labeled K562 cells or
51Cr-labeled P815 cells coated
with 0.15 mg/ml of the anti-FcR
mAb 3G8. Data are expressed as percentage of inhibition of lytic U/106
cells calculated from NK cells incubated in vehicle alone.
Figure 6. Kinase-inactive Syk
inhibits the generation of natural
cytotoxicity. NK cells were in-
fected for 4 h either with vector
control vaccinia (pSC-65) or re-
combinant vaccinia encoding
wild-type Syk, wild-type ZAP-
70, truncated Syk (SykT), ki-
nase-inactive Syk (SykK), or ki-
nase-inactive ZAP-70 (ZAP-
70K). Infected cells were incu-
bated for 4 h with 51Cr-labeled
721.221 cells. Data are expressed
as lytic U/106 cells 6 one stan-
dard deviation.1969 Brumbaugh et al.
sary for natural cytotoxicity, they do not exclude the possi-
bility that under normal circumstances ZAP-70 may
subserve some signaling role.
NK-resistant Targets Fail to Induce Syk Tyrosine Phosphory-
lation. Since our data suggest that Syk is functionally involved
in the development of natural killing, it would follow that
an NK-resistant target might not induce Syk tyrosine phos-
phorylation. Targets sensitive to NK lysis can be made re-
sistant by transfection with an HLA class I molecule, pro-
vided the NK cell expresses a KIR specific for that class I
(for review see reference 39). Since the parental target cell
has only been altered by the addition of class I, we can use
these cells to compare sensitive and resistant targets with the
same triggering ligands. We compared NK-resistant, MHC
class I–transfected C1R cells to the parental class I–deficient
NK-sensitive C1R in their ability to induce Syk tyrosine
phosphorylation. A DX91 NK cell clone expressing the
p70 immunoglobulin superfamily KIR specific for HLA-
B27 (and related HLA-A and -B alleles) was stimulated with
either C1R or C1R-B27 targets before lysing the cells and
immunoprecipitating Syk. The sensitive C1R target stimu-
lated an increase in Syk tyrosine phosphorylation, whereas
stimulation with the resistant C1R-B27 did not result in a
detectable change in Syk tyrosine phosphorylation (Fig. 8
A). This result was extended to include the CD94/
NKG2A/B inhibitory receptors of the C-type lectin super-
family. An NK cell clone expressing the CD94/NKG2A/B
inhibitory receptor that can recognize HLA-B7 was stimu-
lated with C1R or C1R-B7 targets before lysing and im-
munoprecipitating Syk. Again, the sensitive C1R target
stimulated an increase in Syk tyrosine phosphorylation,
whereas the resistant C1R-B7 target did not (Fig. 8 B).
C1R-B27 and C1R-B7 have somewhat higher basal levels
of tyrosine phosphorylated Syk than C1R (see B27 alone
versus C1R alone, Fig. 8 A, B7 alone versus C1R alone,
Fig. 8 B). However, increases in the tyrosine phosphoryla-
tion of NK cell–derived Syk were only seen after incuba-
tion with the NK-sensitive targets. These data suggest that
the ability of a target to generate NK cell–mediated killing
is associated with its capacity to stimulate Syk activation in
NK cells.
Discussion
NK cells exhibit unprimed, natural cytotoxicity against
many different targets (1). Here we examine the mecha-
nisms by which NK cells generate cytotoxicity against a
panel of tumor targets. We demonstrate that the PTK Syk
plays a central role in NK cell–mediated cytotoxicity.
Mechanisms of natural cytotoxicity have been difficult to
study due to the lack of defined triggering receptors. A
number of candidate receptors have been described which
can induce certain aspects of NK cell activation and/or cy-
totoxicity. Among these receptors are adhesion molecules
such as the b1- and b2-integrins (40–44), and other recep-
tors such as CD2 (45), CD69 (46), Lag-3 (47), DNAM-1
(48), KAR (4, 49–57), NK-TR (58), and NKR-P1 (59–
61). Antibodies to some of these receptors can enhance the
killing of FcR-bearing resistant targets (“reverse ADCC”)
as well as stimulating the release of inositol phosphates and
intracellular free Ca21. However, proving the direct in-
volvement of such receptors in the natural killing of spe-
cific tumor targets has often been problematic. Given the
number of NK cell receptors that are candidate triggering
receptors and the broad range of sensitive target cells, the
receptor–ligand interactions involved may be relatively
specific for each effector–target combination. In addition to
the mere presence or absence of triggering receptors on
NK cells or triggering ligands on target cells, the distribu-
tion of these proteins in the cell membrane may be critical.
Helander et al. (44) propose the b2-integrin LFA-1 as a re-
ceptor able to trigger natural cytotoxicity by recognizing its
redistributed ligand ICAM (intracellular adhesion mole-
cule)-2 on diseased versus normal cells. Their results sug-
Figure 7. ZAP-70 is not required for natural cytotoxicity. (A) Whole
cell lysates from normal and ZAP-70–deficient NK cells were resolved by
SDS-PAGE, transferred to membrane, and probed with anti–ZAP-70 an-
tisera (ZAP-70) or anti-Syk mAb (Syk). (B) Normal and ZAP-70–defi-
cient NK cells were incubated for 4 h with 51Cr-labeled 721.221 cells.
Figure 8. MHC class I–bearing,
NK-resistant targets do not stimulate
an increase in Syk tyrosine phospho-
rylation. 107 NK cells were mixed
with 5 3 106 cells of (A) C1R or
C1R-B27, or (B) C1R or C1R-B7.
The reaction mixtures were pelleted
and incubated at 378C for the indi-
cated times. Syk immunoprecipitates
were resolved by SDS-PAGE, trans-
ferred to membrane, and probed
with antiphosphotyrosine mAb (P-1970 Syk in Natural Cytotoxicity
gest that when ICAM-2 is concentrated on the target cell
membrane, LFA-1 can participate in triggering cytotoxic-
ity. Given the potential heterogeneity in triggering recep-
tors required for natural cytotoxicity and the possibility that
ligand distribution on the target cell may be involved, we
used a panel of NK-sensitive tumor targets to stimulate NK
cell clones rather than isolating receptor–ligand interactions
to examine the molecular mechanisms involved in natural
killing. Indeed, our data suggest that for this panel of tar-
gets, the Syk tyrosine kinase plays a common regulatory
role in the generation of natural cytotoxicity.
The molecular mechanisms by which Syk is activated
during natural cytotoxicity are unknown. In contrast to the
poorly defined receptor–ligand interactions involved in
natural cytotoxicity, FcR-initiated killing has a well-defined
receptor and signaling pathway. FcgRIII consists of a ligand-
binding a chain noncovalently associated with homo- or
heterodimers of the CD3-z and FceRIg chains (62–65).
The z and g chains contain ITAMs that are thought to
serve as substrates for Src family PTK (for reviews see refer-
ences 66 and 67). Once these ITAMs are phosphorylated
by Src family PTK, Syk family PTKs can bind to the
ITAM via their SH2 domains and activate downstream
pathways. FcgRIII can induce tyrosine phosphorylation
and activation of both Syk and ZAP-70 (24, 32, 37) but,
similar to natural cytotoxicity, expression of dominant-
negative, kinase-inactive forms of Syk but not ZAP-70 in-
hibit FcR-initiated killing (data not shown). This suggests
that although Syk and ZAP-70 are activated after FcR
cross-linking, ZAP-70 is not required for FcR-mediated
cytotoxicity. These results are consistent with results from
ZAP-70–deficient humans and mice showing no defects in
natural cytotoxicity or ADCC (21–23).
Since our data suggest that Syk is a common signaling el-
ement used by FcR-initiated killing and natural cytotoxic-
ity and since Syk family kinases are thought to dock to
ITAM-containing molecules, this raises the possibility that
ITAM-containing receptor complexes might be involved
in natural cytotoxicity. The known ITAM-containing sub-
units expressed in NK cells, z and g, do not appear to sub-
serve this role in initiating natural cytotoxicity since NK
cells from animals lacking these genes mediate normal nat-
ural killing (68–70). Killer cell activating receptors (KARs),
variants of the KIRs that lack the cytoplasmic inhibitory
motif required to bind the phosphatase SHP-1, have the
capability to initiate NK cell–mediated killing (4, 49–57).
Recent data suggest that KARs coprecipitate proteins with
molecular weights of z12–16 kD (KAR-associated pro-
teins or KARAPs) that are not z or g (71). Although the
molecular identities of these molecules are unknown, two-
dimensional gel analysis suggests that, similar to z and g,
they may be expressed as disulfide-linked dimers. Expres-
sion of KARAPs appears to correlate with the ability of
KARs to activate granule release, since cross-linking KAR
on NK cells, which express KARAP, can trigger cytotoxic-
ity while cross-linking KAR-transfected rat basophilic leu-
kemia cells, which do not express detectable KARAP, does
not induce granule release (71). Molecular cloning of the
KARAP protein will be needed to determine if these are
indeed additional ITAM-containing subunits that are
shared by other triggering–receptor complexes.
Our data clearly suggest that Syk and ZAP-70 are not
functionally redundant in the generation of natural cyto-
toxicity. This observation is consistent with reports dem-
onstrating different activation requirements for each of the
Syk family members. In vitro studies using peptides con-
taining phosphorylated ITAMs from the FceRI g chain
suggest that these peptides can activate Syk kinase activity
(72, 73), whereas ZAP-70 kinase activity is only activated
upon binding a dimeric form of phosphorylated z (74)
rather than peptide fragments (75, 76). In vivo studies in
COS cells suggest that ZAP-70 is only phosphorylated
upon the addition of Lck or Fyn (17), whereas Syk is phos-
phorylated when transfected alone (77, 78). The intrinsic
enzymatic activities of Syk and ZAP-70 also differ when
expressed in COS cells (79). Syk autophosphorylation and
catalytic activity toward the exogenous substrate erythro-
cyte band 3 was z100-fold greater than that of ZAP-70.
Further studies in COS cells expressing chimeric receptors
which cytoplasmically express FceRIg chain coexpressed
with Syk or ZAP-70 showed that the chimeric g plus Syk
led to g phosphorylation and Syk kinase activity while g
plus ZAP-70 induced neither g phosphorylation nor ZAP-
70 activation (20).
The final outcome of an NK cell interacting with a tar-
get cell is determined by the balance of positive and nega-
tive signals transmitted. Positive signals generated during
natural cytotoxicity include activation of PTKs and in-
creases in inositol phosphate and intracellular free Ca21 re-
lease. Negative signals are derived, at least in part, from the
protein-tyrosine phosphatase (PTPase) SHP-1 that is asso-
ciated with MHC–recognizing KIR (5, 8, 80–82). Al-
though it appears the overall balance of positive and nega-
tive signals generated determines the outcome of an NK
cell interacting with a target cell, our data suggest that the
two pathways may directly interact. KIR may preempt the
initiation of a positive signal by acting on the activating re-
ceptor complex or its most proximal signaling molecules.
Since Syk activation is central to the generation of both
natural cytotoxicity and ADCC, SHP-1–mediated dephos-
phorylation of Syk could inhibit cellular activation. Alter-
natively, SHP-1 may act by inactivating a kinase that may
phosphorylate and activate Syk. Recent data suggest that
Syk may be activated by an Src kinase–initiated activation
loop in which, once a small amount of Syk is phosphory-
lated, it can activate other Syk molecules to allow rapid Syk
activation (36). Another potential SHP-1 target is the
ITAM-containing receptor protein that upon phosphoryla-
tion docks Syk family molecules to the receptor complex.
SHP-1 targeting any of these activation steps could inhibit
the Syk tyrosine kinase by either preventing the association
of Syk with the receptor complex or by preventing its full
activation. Valiante et al. (83) have suggested that KIR-associ-
ated SHP-1 inhibits NK cell–mediated natural killing by
dephosphorylating such downstream targets as the phos-
pholipase C (PLC)-g-adaptor protein pp36, thereby pre-1971 Brumbaugh et al.
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